John Kwon is a Vice President in GI Clinical Development at AnaptysBio, having transitioned into this role in 2024. They possess 14 years of experience in basic science and translational research as well as clinical care, previously serving as a faculty member at renowned institutions, including Johns Hopkins University, the University of Chicago, and UT Southwestern, where they directed the clinical IBD program and the Clinical and Translational IBD Research Core. John joined Eli Lilly and Company in 2019 as a Senior Medical Advisor before becoming Executive Director in Clinical Immunology Development at Gilead Sciences in 2021, followed by a position as Senior Director at the Janssen Pharmaceutical Companies from 2022 to 2024. They are pursuing an MD-PhD in Neuroscience at Albert Einstein College of Medicine.
This person is not in any teams
This person is not in any offices